Deglycobleomycin A6 analogues modified in the methylvalerate moiety
摘要:
Previous studies have indicated that the methylvalerate subunit of bleomycin (BLM) plays an important role in facilitating DNA cleavage by BLM and deglycoBLM. Eleven methylvalerate analogues have been synthesized and incorporated into deglycoBLM congeners by the use of solid-phase synthesis. The effect of the valerate moiety in the deglycoBLM analogues has been studied by comparison with the parent deglycoBLM A(5) using supercoiled DNA relaxation and sequence-selective DNA cleavage assays. All of the deglycoBLM analogues were found to effect the relaxation of the plasmid DNA. Those analogues having aromatic C4-substituents exhibited cleavage efficiency comparable to that of deglycoBLM A(5). Some, but not all, of the deglycoBLM analogues were also capable of mediating sequence-selective DNA cleavage. (C) 2011 Published by Elsevier Ltd.
Deglycobleomycin A6 analogues modified in the methylvalerate moiety
摘要:
Previous studies have indicated that the methylvalerate subunit of bleomycin (BLM) plays an important role in facilitating DNA cleavage by BLM and deglycoBLM. Eleven methylvalerate analogues have been synthesized and incorporated into deglycoBLM congeners by the use of solid-phase synthesis. The effect of the valerate moiety in the deglycoBLM analogues has been studied by comparison with the parent deglycoBLM A(5) using supercoiled DNA relaxation and sequence-selective DNA cleavage assays. All of the deglycoBLM analogues were found to effect the relaxation of the plasmid DNA. Those analogues having aromatic C4-substituents exhibited cleavage efficiency comparable to that of deglycoBLM A(5). Some, but not all, of the deglycoBLM analogues were also capable of mediating sequence-selective DNA cleavage. (C) 2011 Published by Elsevier Ltd.
Pyridine Derivatives as Dipeptedyl Peptidase Inhibitors
申请人:Blaszczak Larry Chris
公开号:US20080214616A1
公开(公告)日:2008-09-04
The present invention is directed to compounds of formula (I) or a pharmaceutically acceptable salt thereof; wherein A is (1); X is selected from CH, CF and N; R5 is selected from H, C
1
-C
6
fluoroalkyl, and —OR12; R9 is selected from H —NR13C(O)R14 and —C(O)NR10R11; R12 is selected from H, C
1
-C
6
alkyl and C
3
-C
6
cycloalkyl, for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes.
PYRIDINE DERIVATIVES AS DIPEPTEDYL PEPTIDASE INHIBITORS
申请人:ELI LILLY AND COMPANY
公开号:EP1912946B1
公开(公告)日:2009-05-27
US8133907B2
申请人:——
公开号:US8133907B2
公开(公告)日:2012-03-13
[EN] PYRIDINE DERIVATIVES AS DIPEPTEDYL PEPTIDASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRIDINE EN TANT QU'INHIBITEURS DE DIPEPTEDYL PEPTIDASE
申请人:LILLY CO ELI
公开号:WO2007015767A1
公开(公告)日:2007-02-08
[EN] The present invention is directed to compounds of formula (I) or a pharmaceutically acceptable salt thereof; wherein A is (1); X is selected from CH, CF and N; R5 is selected from H, C1-C6 alkyl, C1-C6 fluoroalkyl, and -OR12; R9 is selected from H -NR13C(O)R14 and -C(O)NR10R11; R12 is selected from H, C1-C6 alkyl and C3-C6 cycloalkyl, for use as inhibitors of the DPP-IV enzyme in the treatment or prevention of conditions including Type II diabetes. [FR] La présente invention concerne des composés de formule I : ou un sel pharmaceutiquement acceptable de ceux-ci ; dans laquelle A est égal à X est choisi parmi CH, CF et N ; R5 est choisi parmi H, C1-C6 alkyle, C1-C6 fluoroalkyle, et -OR12 ; R9 est choisi parmi H -NR13C(O)R14 et -C(O)NRlORl 1 ; R12 est choisi parmi H, C1-C6 alkyle et C3-C6 cycloalkyle, pour une utilisation comme inhibiteurs de l'enzyme DPP-IV dans le traitement ou la prévention de maladies comprenant le diabète de Type II.
Deglycobleomycin A6 analogues modified in the methylvalerate moiety
作者:Xiaoqing Cai、Paul A. Zaleski、Ali Cagir、Sidney M. Hecht
DOI:10.1016/j.bmc.2011.04.047
日期:2011.6
Previous studies have indicated that the methylvalerate subunit of bleomycin (BLM) plays an important role in facilitating DNA cleavage by BLM and deglycoBLM. Eleven methylvalerate analogues have been synthesized and incorporated into deglycoBLM congeners by the use of solid-phase synthesis. The effect of the valerate moiety in the deglycoBLM analogues has been studied by comparison with the parent deglycoBLM A(5) using supercoiled DNA relaxation and sequence-selective DNA cleavage assays. All of the deglycoBLM analogues were found to effect the relaxation of the plasmid DNA. Those analogues having aromatic C4-substituents exhibited cleavage efficiency comparable to that of deglycoBLM A(5). Some, but not all, of the deglycoBLM analogues were also capable of mediating sequence-selective DNA cleavage. (C) 2011 Published by Elsevier Ltd.